Eastern European bioregulator research lineage.
Over 800 peer-reviewed publications on short-chain peptide bioregulators, primarily through the St. Petersburg Institute of Bioregulation and Gerontology and collaborating institutions.
The Opticeutical category is grounded in a specific body of research. The canonical institutional reference for that science is maintained separately.

The bioregulator framework is not a recent commercial construct. It rests on a body of work spanning four decades, with specific anchor publications and an established research institution.
Over 800 peer-reviewed publications on short-chain peptide bioregulators, primarily through the St. Petersburg Institute of Bioregulation and Gerontology and collaborating institutions.
The Dietary Supplement Health and Education Act defines the supplement category in U.S. law. The Opticeutical Standard operates within this framework rather than seeking a new regulatory class.
Neuroendocrinology Letters proposes organ-specific regulatory peptides as information carriers coordinating gene expression within target tissues. The conceptual scaffold for much subsequent bioregulator research.
The 2023 Cell update to the Hallmarks of Aging schema includes epigenetic alteration and intercellular communication disruption. Bioregulators are proposed to operate at the intersection of these two hallmarks.
The bioregulator lineage has been studied at institutional laboratories across Russia, Ukraine, Italy, South Korea, and the United Kingdom. Independent characterization across multiple research groups.
The standard requires per-batch verification by accredited third-party laboratories — USP, NSF, ConsumerLab, or equivalent ISO 17025 accreditation. Identity, potency, and contaminant load on every production batch.
Advanced glycation end products (AGEs) accumulate with age and contribute to tissue stiffening, vascular dysfunction, and inflammatory signalling. Bioregulator-class compounds are proposed to modulate gene-expression patterns that govern protein turnover and the cellular response to glycation stress.
Therapeutic salt carriers — including the proprietary Opti-Salt™ family — provide pharmaceutically defensible vehicles for short-chain peptide stabilisation, dissolution control, and bioavailability across multiple consumer routes of administration.
Two reference surfaces. One category. Different audiences and different angles on the same underlying science.
This site — opticeuticals.com — is the category authority. It defines what an Opticeutical is, publishes the standard a product must meet, and serves the audiences of partners, industry observers, journalists, and informed consumers who interact with the category as a category.
The institutional science underlying the category — the formal discipline of endogenic pharmacology, the bioregulator taxonomy, the full research lineage, the four-layer regenerative model — is maintained at a separate canonical reference at endogenicpharmacology.com, which serves the audiences of researchers, clinicians, and policy stakeholders for whom the scientific depth is the primary value.
The formal definition of endogenic pharmacology as a discipline, the mechanism of working with the body's native regulatory pathways rather than overriding them, and how it differs from conventional exogenic pharmacology.
The full classification of bioregulators, bioregulatory medicine, endoceuticals, and the delivery platforms through which they are administered. The technical depth of the category map.
The full Eastern European research lineage centred on the St. Petersburg Institute of Bioregulation and Gerontology, four decades of published work, and the cross-species evidence base supporting the framework.
The four-layer model of regenerative regulation, from bioelectric signaling through cellular cascade to tissue-level outcomes. The scientific framework for regeneration as an information problem.
The institutional reference for endogenic pharmacology. The discipline, the taxonomy, the research lineage, and the regenerative model.
Open Reference →